CIRP Induces Neutrophil Reverse Transendothelial Migration in Sepsis.


Journal

Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 28 8 2018
medline: 9 6 2020
entrez: 28 8 2018
Statut: ppublish

Résumé

Extracellular cold-inducible RNA-binding protein (CIRP) exaggerates inflammation in sepsis. Neutrophil reverse transendothelial migration (rTEM) allows neutrophils to migrate from tissues into the circulation. The phenotype of neutrophils after reverse migration is CD54CXCR1. We hypothesize that CIRP induces neutrophil rTEM in sepsis. Sepsis was induced in male C57BL/6 mice by cecal ligation and puncture (CLP), and at 5, 10, or 20 h after CLP the frequencies of reversely migrated (RM) neutrophils were assessed in the blood by flow cytometry. As 20 h of CLP showed highest increase in the frequency of RM neutrophils, we further assessed RM neutrophils in the blood of WT and CIRP mice at this time point. The effect of CIRP on neutrophil rTEM was determined by injecting mice with recombinant mouse CIRP (rmCIRP) intratracheally (i.t.) and assessed the frequencies of RM neutrophils. The expression of neutrophil elastase (NE) and junctional adhesion molecule-C (JAM-C) in the lungs was measured by Western blot. The mean frequency of RM neutrophils in sham mice was 0.4%, whereas the frequencies were significantly increased to 1%, 3%, and 7% at 5, 10, and 20 h of CLP, respectively. The mean frequency of RM neutrophils in the blood of CIRP mice was significantly lower than that of WT mice at 20 h of CLP. The RM neutrophils in the blood was significantly increased after administration of rmCIRP i.t. into mice in a time- and dose-dependent manners. NE expression was upregulated, whereas JAM-C expression was downregulated in the lungs after CLP or rmCIRP administration. For the first time, we have showed that CIRP induces neutrophil rTEM in sepsis by increasing NE and decreasing JAM-C.

Identifiants

pubmed: 30148763
doi: 10.1097/SHK.0000000000001257
pmc: PMC6387861
mid: NIHMS1504354
doi:

Substances chimiques

Cell Adhesion Molecules 0
Cirbp protein, mouse 0
Immunoglobulins 0
Jam3 protein, mouse 0
RNA-Binding Proteins 0
Receptors, Interleukin-8A 0
Recombinant Proteins 0
Intercellular Adhesion Molecule-1 126547-89-5
Leukocyte Elastase EC 3.4.21.37

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-556

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM118337
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Sci Rep. 2016 May 24;6:26571
pubmed: 27217302
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Immunol. 2012 Jul 1;189(1):393-402
pubmed: 22634615
Nat Rev Immunol. 2016 May 27;16(6):378-91
pubmed: 27231052
Regen Biomater. 2017 Feb;4(1):55-68
pubmed: 28149530
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Biol Chem. 2016 Jun 1;397(6):497-506
pubmed: 26872312
Am J Pathol. 1997 Jan;150(1):223-34
pubmed: 9006338
Crit Care. 2015 Feb 26;19:53
pubmed: 25887405
Immunity. 2014 Nov 20;41(5):694-707
pubmed: 25517612
Nat Rev Immunol. 2006 Mar;6(3):173-82
pubmed: 16498448
Gene. 1997 Dec 19;204(1-2):115-20
pubmed: 9434172
Sci Rep. 2018 Feb 12;8(1):3052
pubmed: 29434211
Nat Immunol. 2011 Jun 26;12(8):761-9
pubmed: 21706006
Crit Care Med. 2004 Jul;32(7):1460-9
pubmed: 15241089
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Protein Sci. 2009 May;18(5):980-93
pubmed: 19388015
Annu Rev Immunol. 2005;23:197-223
pubmed: 15771570
Immunity. 2015 Jun 16;42(6):1075-86
pubmed: 26047922
Blood. 2016 May 5;127(18):2173-81
pubmed: 27002116
J Leukoc Biol. 2018 Apr;103(4):693-707
pubmed: 29345380
Crit Care. 2009;13(5):R150
pubmed: 19758459
J Immunol. 2017 Jul 15;199(2):750-760
pubmed: 28630091
Shock. 2018 Mar;49(3):269-276
pubmed: 28930914
Nat Med. 2013 Nov;19(11):1489-1495
pubmed: 24097189
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Immunol. 2012 Sep 15;189(6):2689-95
pubmed: 22956760
J Leukoc Biol. 2007 Jan;81(1):1-5
pubmed: 17032697
J Cell Sci. 2004 Apr 1;117(Pt 9):1785-94
pubmed: 15075239
Cell Mol Immunol. 2018 Jan;15(1):38-47
pubmed: 27569563
J Leukoc Biol. 2006 Feb;79(2):303-11
pubmed: 16330528
PLoS One. 2014 Feb 27;9(2):e90426
pubmed: 24587357
Mol Biotechnol. 2013 Jun;54(2):238-49
pubmed: 23589278
J Cell Biol. 1997 May 19;137(4):899-908
pubmed: 9151692
Surgery. 1983 Aug;94(2):331-5
pubmed: 6879447

Auteurs

Hui Jin (H)

Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York.

Monowar Aziz (M)

Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York.

Yasumasa Ode (Y)

Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York.

Ping Wang (P)

Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York.
Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH